Acutaas Chemicals Intrinsic Value
ACUTAAS Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹776.16 | ₹620.93 - ₹931.39 | -56.0% | EPS: ₹35.28, Sector P/E: 22x |
| Book Value Method | asset | ₹643.90 | ₹579.51 - ₹708.29 | -63.5% | Book Value/Share: ₹321.95, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹616.59 | ₹554.93 - ₹678.25 | -65.0% | Revenue/Share: ₹308.29, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹1015.59 | ₹914.03 - ₹1117.15 | -42.4% | EBITDA: ₹420.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹705.28 | ₹564.22 - ₹846.34 | -60.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹528.96 | ₹476.06 - ₹581.86 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹545.08 | ₹490.57 - ₹599.59 | -69.1% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹1123.90 | ₹1011.51 - ₹1236.29 | -36.3% | ROE: 21.8%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹528.96 | ₹476.06 - ₹581.86 | -70.0% | EPS: ₹35.28, BVPS: ₹321.95 |
Want to compare with current market value? Check ACUTAAS share price latest .
Valuation Comparison Chart
ACUTAAS Intrinsic Value Analysis
What is the intrinsic value of ACUTAAS?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Acutaas Chemicals (ACUTAAS) is ₹643.90 (median value). With the current market price of ₹1763.20, this represents a -63.5% variance from our estimated fair value.
The valuation range spans from ₹528.96 to ₹1123.90, indicating ₹528.96 - ₹1123.90.
Is ACUTAAS undervalued or overvalued?
Based on our multi-method analysis, Acutaas Chemicals (ACUTAAS) appears to be trading above calculated value by approximately 63.5%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 29.33 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 1.17 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 21.8% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 31.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.82x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for Acutaas Chemicals
Additional stock information and data for ACUTAAS
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹118 Cr | ₹6 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹125 Cr | ₹-58 Cr | Positive Operating Cash Flow | 6/10 |
| March 2023 | ₹66 Cr | ₹50 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹-12 Cr | ₹-73 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹28 Cr | ₹-23 Cr | Positive Operating Cash Flow | 6/10 |